Dr. Dove has an extensive background in healthcare and leading development-stage life science companies. In addition to his role as chairman of Intera, Dr. Dove also serves on the boards of Serpin Pharma and Atacama Therapeutics. Prior roles include president and CEO of Aeris Therapeutics, which developed and commercialized a treatment for patients with advanced emphysema; president and CEO of Advanced BioHealing, a biotechnology company focused on skin and wound healing; and president and CEO of TEI Biosciences, Inc., a regenerative medicine company. Dr. Dove received his MD degree from New York University and an MBA from the Haas School of Business at U.C. Berkeley.